As of this write up, through its subsidiary Cedar Psychiatry Inc., Novamind has 6 clinics that are operational with 4 more sites set to open up in 2022.įor such an early-stage company in a new industry, we’re impressed to see Novamind is already generating revenue. Novamind ( CSE: NM ) ( OTCQB: NVMDF ) operates a growing network of psychiatric clinics and research sites specializing in ketamine assisted psychotherapy for those suffering from mental illnesses such as PTSD, Suicide Ideation anxiety and depression. These 3 stocks have a strong management teams, ideal share structure, cash on the books and no debt! In today’s article we’ll go over 3 of the top psychedelic stocks we believe are undervalued and a must watch for 2022 as we expect a resurgence of the psychedelic sector. With the rise in popculture around alternative medicines and therapies in recent years, especially in affluent and tech inclined communities, we are in presence of a new era of development of therapeutics and hopeful solutions that is beginning to drive a resurgence in psychedelics and psychedelic therapies to assist those suffering with mental health and addiction.
During that same period, victims and those who suffer any of multiple forms of addiction whether it is opioids, tobacco, alcohol or other substances, have had little to no advancement for the cure of their diseases.
Pharmaceuticals such as Oxycontin have led to substance abuse and opioid addiction. As an example of worst, most people are familiar with the tragedy that is Oxycontin and the lawsuits surrounding Purdue Pharma, the maker of the notorious painkiller which lead to the company pleading guilty to criminal charges resulting in a settlement of $8 Billion. For over a century, the pharmaceutical industry has seen an tremendous amount of growth through breakthrough R&D, patents and mass distribution of its pharmaceuticals to millions of people around the world for both better and worst.
0 kommentar(er)
